Korner does applaud having more options for patients in a group of medicines that's proven to be beneficial beyond weight loss
And its not because its categorically better. It is FDA approved, widely available, and backed by years of trial data on both weight loss and heart protection
It is expected to be commercially available by 2026 or 2027, after the FDA approves the medication.
Both medicines share a broadly similar side-effect profile because both act on GLP-1 pathways
Small but steady weight loss brought gains in confidence, energy, sleep, and quality of life
Medication delivery may look different: Unlike Wegovy, Ozempic, and Zepbound, which come in easy-to-use pen injectors, compounded versions will not be in the same delivery tool as a manufactured version